TrialAutopsyBuilt by Jawad Momani (Pwnedl0l)

Autopsy report · NCT02989870

Sorafenib and Bavituximab Plus SBRT in Unresectable Hepatocellular Carcinoma

Cause of deathSlow enrollment Automatic label, confidence 0.9, unverified. How labels are made.
“No Interest. Investigator was unable to enroll any participants on study.”

The sponsor’s own words in the registry.

Life of this trial

201620172018201920202021Registered2016-12-08Planned start2017-03-27 (planned)Withdrawn (as of)2020-06-05

Vital statistics

Status
Withdrawn
Phase
Phase 1
Sponsor
H. Lee Moffitt Cancer Center and Research Institute
Sponsor type
University, hospital or other
Conditions
HepatoCellular Carcinoma; Unresectable HepatoCellular Carcinoma; Liver Cancer
Interventions
Stereotactic Body Radiation Therapy (SBRT); Sorafenib; Bavituximab
Participants
0
Sites
1
Countries
United States

Trials that died the same way

Look deeper

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.